| 因素 | N | PLR | P | |
| 低值 | 高值 | |||
| 患者总数 | 214 | 78 | 136 |
|
| 年龄(SD) | 60.29 (±9.353) |
|
| 0.754 |
| 性别 |
|
|
|
|
| 男性 | 128 (59.8%) | 50 | 78 | 0.332 |
| 女性 | 86 (40.2%) | 28 | 58 |
|
| 黄疸 |
|
|
| 0.004 |
| 有 | 85 (39.7%) | 21 | 64 |
|
| 无 | 129 (60.3%) | 57 | 72 |
|
| CA19-9 |
|
|
|
|
| ≤114 | 78 (36.4%) | 36 | 42 | 0.025 |
| >114 | 136 (63.6%) | 42 | 94 |
|
| 白蛋白 |
|
|
|
|
| ≥30 | 205 (95.8%) | 78 | 127 | 0.020 |
| <30 | 9 (4.2%) | 0 | 9 |
|
| 总胆红素 |
|
|
|
|
| 0~35 | 120 (56.1%) | 44 | 76 | <0.001 |
| 35~200 | 44 (20.6%) | 16 | 28 |
|
| >200 | 50 (23.4%) | 18 | 32 |
|
| 谷丙转氨酶 |
|
|
|
|
| 0~100 | 133 (62.1%) | 48 | 85 | 0.005 |
| >100 | 81 (37.9%) | 30 | 51 |
|
| 谷草转氨酶 |
|
|
|
|
| 0~80 | 150 (70.1%) | 55 | 95 | 0.001 |
| >80 | 64 (29.9%) | 23 | 41 |
|
| C-反应蛋白 |
|
|
| 0.214 |
| ≤0.5 | 117 (54.7%) | 43 | 74 |
|
| >0.5 | 97 (45.3%) | 35 | 62 |
|
| 胰腺炎 |
|
|
| 0.950 |
| 有 | 8 (3.7%) | 3 | 5 |
|
| 无 | 206 (96.3%) | 75 | 131 |
|
| 腹痛 |
|
|
| 0.600 |
| 有 | 183 (85.5%) | 67 | 116 |
|
| 无 | 31 (14.5%) | 11 | 20 |
|
| 糖尿病 |
|
|
| 0.264 |
| 有 | 46 (21.5%) | 17 | 29 |
|
| 无 | 168 (78.5%) | 61 | 107 |
|
| 肿瘤位置 |
|
|
| 0.003 |
| 头 | 140 (65.4%) | 51 | 89 |
|
| 体 | 54 (25.2%) | 20 | 34 |
|
| 尾 | 20 (9.3%) | 7 | 13 |
|
| 肿瘤大小 |
|
|
| 0.004 |
| ≤2 cm | 27 (12.6%) | 10 | 17 |
|
| >2 cm, ≤4 cm | 137 (64.0%) | 50 | 87 |
|
| >4 cm | 50 (23.4%) | 18 | 32 |
|
| 手术方式 |
|
|
|
|
| 胰十二指肠切术 | 140 (65.4%) | 51 | 89 | 0.007 |
| 胰体尾切除术 | 74 (34.6%) | 27 | 47 |
|